Cargando…

Therapeutic Strategies for SARS-CoV-2 acting on ACE-2

Detalles Bibliográficos
Autores principales:	Vitiello, A., Ferrara, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526529/ https://www.ncbi.nlm.nih.gov/pubmed/33010419 http://dx.doi.org/10.1016/j.ejps.2020.105579

Ejemplares similares

Drugs acting on the renin–angiotensin system and SARS-CoV-2
por: Vitiello, Antonio, et al.
Publicado: (2021)

Colchicine and SARS-CoV-2: Management of the hyperinflammatory state
por: Vitiello, Antonio, et al.
Publicado: (2021)

Association between microbiota and immune response to Sars-CoV-2 infection
por: Vitiello, A., et al.
Publicado: (2023)

The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021)

The advantages of drug treatment with statins in patients with SARS-CoV-2 infection
por: Ferrara, Francesco, et al.
Publicado: (2021)

Correction to: The renin‑angiotensin system and specifically angiotensin‑converting enzyme 2 as a potential therapeutic target in SARS‑CoV‑2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021)

COVID-19 vaccines and decreased transmission of SARS-CoV-2
por: Vitiello, A., et al.
Publicado: (2021)

Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2
por: Castiglione, Gianni M., et al.
Publicado: (2021)

Scientific Hypothesis for Treatment of COVID‐19′s Lung Lesions by Adjusting ACE/ACE2 Imbalance
por: Ferrara, F., et al.
Publicado: (2021)

The direct correlation between microbiota and SARS-CoV-2 infectious disease
por: Vitiello, Antonio, et al.
Publicado: (2023)

An ace model for SARS-CoV-2 infection
por: Major, Jack, et al.
Publicado: (2020)

ACE2 diversity in placental mammals reveals the evolutionary strategy of SARS-CoV-2
por: Fam, Bibiana S.O., et al.
Publicado: (2020)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

ACE2: the molecular doorway to SARS-CoV-2
por: Medina-Enríquez, Miriam Marlene, et al.
Publicado: (2020)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, E. P., et al.
Publicado: (2020)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
por: Anand, Sai Priya, et al.
Publicado: (2020)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, Emilia P., et al.
Publicado: (2021)

Oral cancer and ACE2 receptor of SARS-CoV-2
por: Martelli-Júnior, Hercílio, et al.
Publicado: (2020)

ACE2-independent infection of T lymphocytes by SARS-CoV-2
por: Shen, Xu-Rui, et al.
Publicado: (2022)

The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor
por: Brielle, Esther S., et al.
Publicado: (2020)

The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Gong, Yanqiu, et al.
Publicado: (2021)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

Potential therapeutic and pharmacological strategies for SARS-CoV2
por: Ghareeb, Doaa A., et al.
Publicado: (2021)

ACE2, SARS-CoV-2 und RAAS-Blocker
por: Kintscher, Ulrich, et al.
Publicado: (2021)

Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
por: Lazartigues, Eric, et al.
Publicado: (2020)

Endocrine significance of SARS-CoV-2’s Reliance on ACE2
por: Chappell, Mark C
Publicado: (2020)

ACE2-Independent Alternative Receptors for SARS-CoV-2
por: Lim, Suhyeon, et al.
Publicado: (2022)

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
por: Sharifkashani, Sourena, et al.
Publicado: (2020)

Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection
por: Shukla, Nidhi, et al.
Publicado: (2021)

Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication
por: Pang, Xiaocong, et al.
Publicado: (2020)

The molecular basis for SARS-CoV-2 binding to dog ACE2
por: Zhang, Zengyuan, et al.
Publicado: (2021)

ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection
por: Wang, Zai, et al.
Publicado: (2021)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
por: Hatmal, Ma’mon M., et al.
Publicado: (2020)

Distinct Differences in the Interactions of Receptor Binding Domains of SARS-CoV-2 and SARS-CoV with Human ACE2
por: Acharya, Atanu, et al.
Publicado: (2021)

Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
por: Ali, Amanat, et al.
Publicado: (2020)

Structural dynamic changes in the SARS-CoV and SARS-CoV-2 S spike assemblies upon ACE2 activation
por: Chen, Chengbo, et al.
Publicado: (2022)

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2
por: Wu, Lili, et al.
Publicado: (2020)

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
por: Schieffer, Elisabeth, et al.
Publicado: (2022)

Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
por: Nguyen, Hoang Linh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vgh88gq1l9kvd7cfsu25o4knhm